Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli

Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli

Thumbnail Image
Download
Name

Stephanopoulos_Isoprenoid pathway.pdf

Size

1.41 MB

Format

Adobe PDF

Checksum (MD5)

33fd2315a69c140a022bb3c02435d822

Author(s)
Wang, Y.
•
Phon, T. H.
•
Pfeifer, B.
•
Ajikumar, Parayil Kumaran
•
Xiao, Wen-Hai
•
Tyo, Keith E. J.
•
Simeon, Fritz
•
Tyo, Keith E. J.
•
Leonard, Effendi
•
Mucha, Oliver
more
Date Issued
September 2010
Journal
Science
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Ajikumar, P. K., W.-H. Xiao, K. E. J. Tyo, Y. Wang, F. Simeon, E. Leonard, O. Mucha, T. H. Phon, B. Pfeifer, and G. Stephanopoulos. “Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli.” Science 330, no. 6000 (September 30, 2010): 70-74.
Version
Author's final manuscript
Abstract
Taxol (paclitaxel) is a potent anticancer drug first isolated from the Taxus brevifolia Pacific yew tree. Currently, cost-efficient production of Taxol and its analogs remains limited. Here, we report a multivariate-modular approach to metabolic-pathway engineering that succeeded in increasing titers of taxadiene—the first committed Taxol intermediate—approximately 1 gram per liter (~15,000-fold) in an engineered Escherichia coli strain. Our approach partitioned the taxadiene metabolic pathway into two modules: a native upstream methylerythritol-phosphate (MEP) pathway forming isopentenyl pyrophosphate and a heterologous downstream terpenoid–forming pathway. Systematic multivariate search identified conditions that optimally balance the two pathway modules so as to maximize the taxadiene production with minimal accumulation of indole, which is an inhibitory compound found here. We also engineered the next step in Taxol biosynthesis, a P450-mediated 5α-oxidation of taxadiene to taxadien-5α-ol. More broadly, the modular pathway engineering approach helped to unlock the potential of the MEP pathway for the engineered production of terpenoid natural products.
Description
Author Manuscript February 6, 2011
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0
http://creativecommons.org/licenses/by-nc-sa/3.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/81256
DOI of Published Version
https://doi.org/10.1126/science.1191652
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.